System Status Messages

Time Market Status
22:23:48 ETNASDAQ
BX
Post - Trade
PSX
NASDAQ Options
BX Options
PHLX
NASDAQ Futures
ISE
GEMX
MRX
Systems are operating normally

Regulatory Messages

Time Market Status
16:09:33 ETNASDAQ
BX
PSX

Trading in Porch Group Inc. - Warrant (PRCHW) was halted today at 16:05:05 ET due to additional information requested from the company related to the redemption of the warrants today. It is anticipated (PRCHW) will be suspended on Nasdaq effective 4/19/21. Please call +1-800-537-3929 or +1-301-978-8500 if you have any questions.



IPO Messages

Time Market Status
16:24:56 ETPHLXNasdaq PHLX has approved the transfer of GFN from Wolverine Trading to Belvedere Trading effective before the opening of business on Monday, April 19, 2021. Please contact Nasdaq Option Listings at 215-496-1266 with any questions.

12:44:14 ETNASDAQ

IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) has officially opened for trading.

Time: 12:41:15
Price: $30
Shares: 1,048,729

For additional information please contact Nasdaq Trading Services at (212) 231-5180.





12:39:34 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:30:08 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:19:08 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:10:59 ETNASDAQ

IPO Notice Update: The initial public offering of AKOYA BIOSCIENCES, INC (AKYA) has officially opened for trading.

Time: 12:09:34
Price: $26.00
Shares: 459,630

For additional information please contact Nasdaq Trading Services at (212) 231-5180.





12:09:07 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:06:29 ETNASDAQIPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



12:00:07 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:55:23 ETNASDAQIPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:52:58 ETNASDAQ

IPO Notice Update: The initial public offering of company BIOMEA FUSION, INC  (BMEA) has officially opened for trading.

Time:11:51:12
Price: $20.00
Shares:341,119

For additional information please contact Nasdaq Trading Services at (212) 231-5180.





11:50:32 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:45:01 ETNASDAQIPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:41:29 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:40:02 ETNASDAQIPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:36:51 ETNASDAQIPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:31:13 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:30:18 ETNASDAQIPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:25:10 ETNASDAQIPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:21:28 ETNASDAQIPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:20:37 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:15:23 ETNASDAQIPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:12:13 ETNASDAQIPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:10:08 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:05:29 ETNASDAQIPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:01:25 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:56:21 ETNASDAQIPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:50:18 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:50:04 ETNASDAQIPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:42:03 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:41:43 ETNASDAQIPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:30:25 ETNASDAQIPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:30:20 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:20:08 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:10:19 ETNASDAQIPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



07:53:01 ETNASDAQIPO Notice: The initial public offering of Akoya BioSciences, Inc. (AKYA) will be released on Nasdaq today for quotation at 10:35 a.m. ET and will be eligible for trading at approximately 10:45 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.


07:44:43 ETNASDAQIPO Notice: The initial public offering of Biomea Fusion, Inc. (BMEA) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.


07:33:38 ETNASDAQIPO Notice: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) will be released on Nasdaq today for quotation at 9:50 a.m. ET and will be eligible for trading at approximately 10:00 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.



Self-Help Messages

Time Market Status
22:24:02 ETNASDAQ
BX
PSX
NASDAQ Options
NASDAQ Futures
BX Options
PHLX
ISE
GEMX
MRX
There are no messages available